ARYx Therapeutics Inc ARYX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.01
- Market Cap
- $33.46
- Volume/Avg
- 100 / 1,546
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
ARYx Therapeutics Inc is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates designed to eliminate known safety issues associated with well-established, commercially successful drugs.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 56
- Website
- http://www.aryx.com
Competitors
Valuation
|
Metric
|
ARYX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ARYX
|
|---|---|
Quick Ratio | 0.38 |
Current Ratio | 0.47 |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
ARYX
|
|---|---|
Return on Assets (Normalized) | −166.11% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −216.01% |
Return on Assets
No chart available
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Qhpwx | $81.1 Bil | |
MKKGY
| Merck KGaA ADR | Tgrlpv | $76.4 Bil | |
HLN
| Haleon PLC ADR | Cpb | $38.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Tnh | $11.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Ssh | $11.0 Bil | |
VTRS
| Viatris Inc | Vhtw | $11.0 Bil | |
CTLT
| Catalent Inc | Crtmq | $7.0 Bil | |
PRGO
| Perrigo Co PLC | Jymr | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Grznvps | $2.8 Bil | |
CURLF
| Curaleaf Holdings Inc | Gxkt | $2.5 Bil |